Skip to main content
Glama

Pulsedive

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Even though annotations already declare readOnly/openWorld/idempotent/destructive hints, the description goes far beyond them: it discloses internal cascading through multiple endpoints, graceful degradation when GLEIF/OpenFIGI are unavailable, resolution of non-US issuers via ISIN-to-LEI mapping, the behavior of returning `figi_candidates` when ambiguous, and explicit `unresolved` output. This level of detail is highly valuable for an agent predicting side effects and edge cases.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but every segment earns its place: usage trigger, supported types, resolution details, edge cases, degradation behavior, and parameter guidance. While it could be tightened, the density of actionable information justifies the length. It is well-organized with clear sections ('SUPPORTED TYPES', 'LEI/FIGI enrichment'), making it scannable despite its size.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with only 2 parameters and no output schema, the description provides a remarkably complete picture. It explains what outputs can be expected (identifiers with source labels, unresolved lists, candidate lists), how to handle ambiguous inputs, and what fallback behavior occurs. An agent is unlikely to need additional context to invoke this tool correctly, even among 30+ siblings in a large toolset.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already covers both parameters at 100%, but the description adds critical semantic context beyond enum descriptions. It elaborates on the 'value' parameter with concrete examples per type (ticker, CIK, ISIN, name for company; brand/generic for drug), warns against including security-class words, clarifies that non-ticker instruments still resolve, and explains how ISIN maps to legal entities. This is exactly the kind of nuance an agent needs to call it correctly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb+resource: 'resolve a user-spoken NAME to the canonical/official identifiers'. It lists concrete query examples and explicitly distinguishes itself from tools that consume those identifiers (e.g., 'other tools require as input'). The 'SUPPORTED TYPES' section further clarifies scope for company and drug entities, making it unmistakably distinct from siblings like 'entity_profile' or 'compare_entities'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description opens with explicit when-to-use guidance: 'Use FIRST whenever you have a name but need an ID.' It also tells the agent what not to do via the `value` parameter instruction: 'never the question's full noun phrase'. It explains edge cases like non-equity instruments and what happens when a name matches multiple instruments, guiding the agent on expected behavior without needing to inspect schemas.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Many tools have overlapping purposes, e.g., five 'ask_pipeworx' variants and multiple prediction market tools with subtle distinctions. An agent would struggle to pick the correct tool without careful reading of long descriptions.

Naming Consistency4/5

Most tools follow a verb_noun pattern with domain prefixes (pipeworx_, polymarket_, pulsedive_), but a few standalone verbs (forget, recall) break the pattern slightly. Overall consistent within groups.

Tool Count3/5

33 tools is on the heavy side, but the server covers a broad range of domains (data querying, prediction markets, security, subscriptions). The count is borderline but not excessive given the scope.

Completeness4/5

The tool set covers a wide array of operations: querying, entity analysis, comparisons, prediction market edge detection, subscriptions, memory, and scanning. Minor gaps exist (e.g., limited to Polymarket/Kalshi for prediction markets), but overall the surface is comprehensive.